Responsibility

Why Health Literacy matters to us at MSD

September 2022

Share this article

.st0{fill:#00857C;}

Antibodies. Variants. Transmissibility. Who would have ever thought we’d use words like these in everyday life?

The Covid-19 pandemic has highlighted how important it is to understand health information to help keep ourselves and our families, friends and communities healthy.

Improving health literacy – defined as a person’s ability to find, understand and use information and services to make health-related decisions for themselves and others – is important to health situations across the board, from disease prevention options to clinical trials to cancer, HIV, diabetes, cardiovascular disease and many others.

Getting information that is accurate, relevant and presented in a meaningful way is challenging- especially in the digital age where we might have to navigate often contradictory health messages or even misinformation. As a pharmaceutical company, MSD has a vital role to play in ensuring that the information we provide to the people who are prescribed our medicines reaches the highest standards.

It is for this reason we have committed to joining the Patient Information Forum’s PIF-TICK standard . Being part of the scheme not only means we should be assuring accuracy, but also co-creating health information with the people it is being made for. It also means working collaboratively with organisations who know the communities most affected by the diseases and conditions we work in. Our policy statement on patient information creation can be found here

Why improving health literacy is urgent

The Patient Information forum say that:

  • 1 in 6 in UK have very low literacy skills[i], [ii]
  • up to 1 million people in UK cannot speak English well or at all[iii]

Knowing that this will impact on health inequality and outcomes means we know we need to do a better job at meeting people where they are and on their terms.

How we’re making health information easier to understand

Internationally, some of the ways we’re improving health literacy in our own communications include:

  • Creating easy-to-read patient labels
  • Improving packaging and instructions for use
  • Developing easy-to-understand disease education materials
  • Improving health literacy in clinical trials
  • Sharing best practices externally

There is always more we can do and we aim to keep improving.

Have you seen some MSD patient materials or information?

What did you think?

We would love suggestions on how we could do better and things we should do more of. Email our Medical Information team at: medicalinformationuk@msd.com


[i] Survey of Adult Skills 2012 oecd.org/skills/piaac

[ii] Skills for Life 2011 assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/36000/12-p168-2011-skills-for-life-survey.pdf

[iii] www.ethnicity-facts-figures.service.gov.uk/uk-population-by-ethnicity/demographics/english-language-skills/latest

GB-NON-06409 | Date of Preparation: September 2022

Partnerships

MSD launches Fifty Over 50: Giving people growing older with HIV a voice

September 2022

Share this article

.st0{fill:#00857C;}

A unique listening project in partnership with several leading HIV organisations, with a mission to hear from people who are growing older with HIV.

Thanks to decades of clinical research, innovation and cross-sector collaboration, HIV has largely become a chronic condition in the UK. The UK has led the way in achieving the UNAIDS targets of 90% of people living with HIV knowing their HIV status, of those with a known HIV diagnosis 90% receiving treatment, and of those receiving treatment 90% having an undetectable viral load.

The progress which has been made through improvements in testing and treatment has been remarkable, and new diagnoses of HIV continue to decrease in the UK. However, as the number of people who are now growing older with HIV increases, this brings with it a host of new or additional challenges.

The Fifty Over 50 project, coordinated by MSD in collaboration with the Whole Person Care group of HIV community and professional organisations, is a unique listening exercise which set out to give people growing older with HIV a voice. Fifty Over 50 brings together first-hand accounts from a diverse range of people living with HIV aged 50+, and highlights how for many in the HIV community being well is about more than just viral suppression, it’s also about living well.

Ben Lucas, Managing Director for MSD in the UK and Ireland, commented:

“I am immensely proud that MSD have worked with all the individual contributors and organisations that form part of Fifty Over 50 – providing a platform for people to share their experiences and shine a light on the changes that are needed to support people living with HIV to live well across the entirety of their life.”

Learn more about Fifty Over 50 and hear what our contributors had to share in the e-book here.

GB-NON-06155 | Date of Preparation: July 2022

Responsibility

Over 100 hours of volunteering – Employees ‘Give Back’

September 2022

Share this article

.st0{fill:#00857C;}

As part of MSD’s volunteering policy – employees attended a 2 day event with a London charity

In the first week of July, members of our Early Talent Forum, comprised of student placements, graduates, and apprentices, utilised MSD’s volunteering leave policy to collectively commit over 100 hours of volunteering at The Passage – London’s largest voluntary sector day centre for homeless and vulnerable people.

Across 2 days, they worked intensely to prepare food for a fundraising event. The sessions were held at The Passage’s Resource Centre in Westminster, where the charity provides immediate services like meals, showers, laundry, medical appointments, and substance misuse and mental health support.

Our volunteers were called upon to help preparations for The Passages annual Summer Garden Party. Rolling their sleeves up for two busy days of chopping, slicing, and dicing, our volunteers helped ready a buffet of food items, including hulling 250 punnets of strawberries, dicing over 200 onions, and packaging 200+ tubs of coleslaw, salad, and salsa.

The impact of their work was imminently felt. ‘We only have two permanent chefs’ Fran Hodge, Volunteering Manager at the Passage told our volunteers, ‘They’re fun and they run a tight ship.’ With only two days to go before the big event, and preparations to be made for over 500+ people, our early talent volunteers were eager and active in fulfilling their culinary duties.

The event was labelled a ‘gleaming success’ and fundraised for the hundreds of vulnerable people and rough sleepers the Passage aids, helping them to live safe, happy and fulfilling live.

Having completed his volunteering session feeling freshly fulfilled, ETF co-lead and volunteer co-ordinator, Sam Rogers, reflects on his experience ‘MSD’s volunteering policy speaks to something that is intrinsic to everyone in the company – a want to ‘give back’. We really want to thank all the wonderful people at The Passage. It was inspiring to see the passion and hard work behind what you do and rewarding for us to get an insight into your world and lend a helping hand’’

GB-NON-06233 | Date of Preparation: July 2022

Responsibility

Celebrating 10 years of the RTC Fellowship for Global Health

September 2022

Share this article

.st0{fill:#00857C;}

This year, 32 of our employees from around the world will be supporting the efforts of Non-Governmental Organisations (NGOs) through our Richard T. Clark Fellowship for Global Health programme.

Every year, a cohort of global employees enrol onto the company’s three-month corporate pro bono programme. Through leveraging the skills and knowledge of our Fellows, the programme aims to assist our NGO partners in strengthening their capacity and reach with technical and human capital support; in turn providing increased access to health services, products and education to their local communities. Though the programme is only three months in length, the impact that the Fellowship has on the NGO partners, MSD in the UK, and its employees lasts long after the project’s completion.

2022 marks the tenth year of the Fellowship programme, and this year, thirty-two employees from 13 countries will serve as RTC Fellows from July 25th to October 7th. The Fellows will work in small cross-functional teams across 11 global projects, serving communities across Africa, Asia, Europe and Latin America in a diverse range of areas including clinical research, oncology, supply chain, and sexual health.

MSD in the UK is delighted that two of our employees, Nat Philips and Sara Khan, will be participating in this year’s Fellowship.

Always seeking new opportunities to grow, Internal Communications Senior Specialist Nat Philips is passionate about making a difference to the health outcomes to the populations that she works with:

‘The RTC Fellowship has been on my radar since I joined MSD in 2014, but it is only since it became a remote opportunity during COVID that I felt able to apply. I am excited to be able to join a programme where my knowledge and skills accrued across 25 years in the public and commercial sectors can be utilised to benefit others at a global scale; and I am curious to what I will learn from undertaking this project that will benefit my role at MSD when I return to work in October.’

With a background in primary care, Associate Director Medical Affairs Sara Khan is excited to make a difference through her work with the programme:

‘Prior to joining MSD, I was a Primary Care Physician with an interest in global and public health, and so when I first heard about the RTC Fellowship, I was immediately drawn to it and envisaged it being deeply rewarding. I also felt it would suit my skillset, meaning I could provide effective and impactful support to the NGOs that are part of the fellowship. I am excited about the programme starting, working in a small global team, and seeing what we can achieve during the 3-month programme!’

We wish Nat and Sara well on their Fellowship journeys, and look forward to hearing more about their experiences once they return!

GB-NON-06123 | Date of Preparation: June 2022

Innovation

MSD signs lease on Discovery Centre and UK HQ in London

May 2022

Share this article

.st0{fill:#00857C;}

[Photo: Artist impression of future new Discovery Centre and Headquarters in London]

This will be a new, 25,000 square metre specialised office life sciences laboratory and office facility strategically located at the heart of London’s Knowledge Quarter

MSD announced today that the Belgrove House site, carefully identified as the location of choice for a £1bn life sciences investment by the US biopharmaceutical company has been secured.

This long-term lease will allow MSD to develop a Discovery Centre and UK HQ with the aim of ensuring that innovation is at the heart of drug discovery, whilst its position in the Kings Cross area will provide proximity to leading UK academic and industry research, access to Europe, as well as offer unique collaboration opportunities.

MSD has worked collaboratively with developer, Precis Advisory Ltd., Camden Council and the local community to get to this stage. Once developed, the discovery research centre and HQ will be home to 800 MSD employees, ranging from discovery research, clinical and support roles, to marketing, finance, and administration. 

Currently, MSD has a growing discovery research team located at the London BioScience Innovation Centre and the neighbouring Francis Crick Institute. The teams have established successful scientific collaborations with leading UK institutions including The Crick and Kings College London, as well as European biotechnology companies. In addition, MSD is a founding member of Our Future Health in the UK, and an active participant in several research consortia focused in the area of neurodegeneration, one of the biggest challenges facing healthcare.

The Belgrove House development will meet high environmental sustainability standards.  MSD will also be delivering an ambitious educational outreach programme in collaboration with Camden STEAM and is steadfast in its commitment to giving back to the local community through investment, volunteering and by providing areas of the building for the public to access and use.

The developer plans to undertake the initial demolition phase this year, with construction expected to start by early 2023, finalising in late 2027.

In early 2021, MSD’s UK HQ moved from Hertfordshire to interim offices in Moorgate to be part of a thriving life-sciences ecosystem, with unrivalled access to talent and connectivity.

Speaking, following progress to exchange on the lease, Dr Fiona Marshall, Senior Vice President and Head of Discovery, Preclinical and Translational Medicine at MSD, commented:

“MSD is proud to be delivering on our UK investment plans, with a future that puts our scientists at the heart of a vibrant centre for innovation and technology development alongside leading research institutes which include some of our current research collaboration partners.  Our mission to discover and develop therapeutics that address unmet medical needs for patients with diseases of ageing is underway in earnest, harnessing the passion and potential of world-leading scientific minds across industry and academia.”

Ben Lucas, Managing Director for MSD in the UK and Ireland, commented:

“We are delighted to have signed the lease on Belgrove House, moving us tangibly forwards in our mission to save and improve lives through investing in pioneering science.  MSD is aligned to the UK’s Life Sciences Vision and committed to playing a leading role in the ecosystem here, with a focus on an innovation partnership with UK Government and the NHS that delivers for patients.  Locally, we are focused on building a strong connection with the community and on contributing positively through our work to such a vibrant environment.”

Rajesh Agrawal, Deputy Mayor of London for Business, commented:

“I am delighted that London will be the home of MSD’s new Discovery Research Centre and UK Headquarters, further boosting London’s position as a world-leading life sciences hub.”

[Photo: Artist impression of future new Discovery Centre and Headquarters in London]

GB-NON-09398 | May 2024